ArticleDiagnostics (Basel, Switzerland)2020

The Over-Expression of E2F3 Might Serve as Prognostic Marker for Neuroblastoma Patients with Stage 4S Disease.

Stefano Parodi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.